Aeterna Zentaris Reports Third Quarter 2022 Financial Results

Provided By Globe Newswire

Last update: Nov 3, 2022

– Company ended the quarter with $53.8 million in cash

– Driving continued progress across diversified pre-clinical and clinical development pipeline